rs760889414
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005956.4(MTHFD1):c.673G>T(p.Glu225Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005956.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFD1 | NM_005956.4 | c.673G>T | p.Glu225Ter | stop_gained | 8/28 | ENST00000652337.1 | NP_005947.3 | |
MTHFD1 | NM_001364837.1 | c.673G>T | p.Glu225Ter | stop_gained | 8/27 | NP_001351766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFD1 | ENST00000652337.1 | c.673G>T | p.Glu225Ter | stop_gained | 8/28 | NM_005956.4 | ENSP00000498336 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251480Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135918
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727240
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia Pathogenic:2
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Oct 15, 2018 | This variant is interpreted as Pathogenic, for Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, autosomal recessive. The following ACMG Tag(s) were applied: PS3 => Well-established functional studies show a deleterious effect (https://www.ncbi.nlm.nih.gov/pubmed/25633902). PVS1-Strong => PVS1 downgraded in strength to Strong. PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (https://www.ncbi.nlm.nih.gov/pubmed/25633902). PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 21, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2022 | ClinVar contains an entry for this variant (Variation ID: 446307). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with methylenetetrahydrofolate dehydrogenase 1 deficiency (PMID: 25633902). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs760889414, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Glu225*) in the MTHFD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTHFD1 are known to be pathogenic (PMID: 21813566, 25633902). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at